Hospice News December 16, 2021
Amedisys (NASDAQ: AMED) will be honing its acquisitional focus more towards the home health care space heading into next year. Soaring valuations in hospice, along with a crowded market and the complexity of integrating these assets are among the factors pulling the company’s gaze, according to CEO Paul Kusserow.
The hospice merger and acquisitions market has been hot in recent years, with a rising volume of deals taking place and record-high valuations outpacing those in other health care sectors. Multiples in the hospice and home care space hit a record 26x, according to a report by PwC’s Health Research Institute.
The pace and price tags in a frothy hospice market has some strategic buyers looking elsewhere as 2022 rolls in....
Today's Sponsors
Today's Sponsor